Caption Management, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,970,000
-12.6%
120,0000.0%0.05%
-23.3%
Q2 2023$3,398,400
+29.7%
120,000
+5.2%
0.06%
+17.6%
Q1 2023$2,620,555
+55.5%
114,086
+90.1%
0.05%
+96.2%
Q4 2022$1,684,800
-58.9%
60,000
-58.6%
0.03%
-54.4%
Q3 2022$4,100,000
-8.6%
145,000
-5.8%
0.06%
+5.6%
Q1 2022$4,484,000
+4.1%
154,000
+17.6%
0.05%
+12.5%
Q4 2021$4,308,000
-34.3%
131,000
+10.1%
0.05%
-44.2%
Q2 2021$6,560,000
+62.9%
119,000
+52.6%
0.09%
-1.1%
Q1 2021$4,028,000
-4.2%
78,000
-19.6%
0.09%
-9.4%
Q4 2020$4,204,000
+13.2%
97,000
-8.5%
0.10%
+11.6%
Q3 2020$3,713,000
-34.5%
106,0000.0%0.09%
-54.5%
Q2 2020$5,671,000
+188.2%
106,000
+91.0%
0.19%
+70.3%
Q1 2020$1,968,000
-43.9%
55,500
-24.5%
0.11%
-5.9%
Q4 2019$3,508,000
-68.7%
73,500
-78.7%
0.12%
-79.8%
Q3 2019$11,194,000345,6000.58%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders